Advertisement
Advertisement
IMMP
Immutep Limited - ADR
0.45
USDSponsored
+0.01
+3.15%
May 08, 15:56 UTC -4
Closed
After-Market
0.45
0.00
+0.45%
IMMP Earnings Reports
Positive Surprise Ratio
IMMP beat 6 of 10 last estimates.
60%
Next Report
Date of Next Report
Jul 29, 2026
Estimate for Q4 26 (Revenue/ EPS)
$12.06M
/$0.00
Implied change from Q2 26 (Revenue/ EPS)
+55.93%
/-100.00%
Implied change from Q4 25 (Revenue/ EPS)
+294.81%
/-100.00%
Immutep Limited - ADR earnings per share and revenue
On Jan 29, 2026, IMMP reported earnings of -0.03 USD per share (EPS) for Q2 26, missing the estimate of -0.02 USD, resulting in a -9.89% surprise. Revenue reached 7.74 million, compared to an expected 17.52 million, with a -55.86% difference. The market reacted with a -2.94% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 2 analysts forecast an EPS of 0.00 USD, with revenue projected to reach 12.06 million USD, implying an decrease of -100.00% EPS, and increase of 55.93% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Werewolf Therapeutics, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.29
Actual
-$0.28
Surprise
+3.68%
argenx SE - ADR
Report Date
May 07, 2026 For Q1 26
Estimate
$5.47
Actual
$5.52
Surprise
+0.86%
Arrowhead Research Corporation
Report Date
May 07, 2026 For Q2 26
Estimate
-$1.16
Actual
-$0.93
Surprise
+20.32%
ImmunityBio, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.09
Surprise
-26.05%
Stoke Therapeutics, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.84
Actual
-$0.79
Surprise
+6.34%
ANI Pharmaceuticals, Inc.
Report Date
May 08, 2026 For Q1 26
Estimate
$1.33
Actual
$2.04
Surprise
+54.04%
Harmony Biosciences Holdings, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.72
Actual
$0.55
Surprise
-24.16%
CytomX Therapeutics, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.12
Actual
-$0.10
Surprise
+18.83%
Tectonic Therapeutic, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$1.20
Actual
-$1.34
Surprise
-11.07%
ALX Oncology Holdings Inc. Common Stock
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.17
Surprise
+24.24%
FAQ
What were Immutep Limited - ADR's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Immutep Limited - ADR reported EPS of -$0.03, missing estimates by -9.89%, and revenue of $7.74M, -55.86% below expectations.
How did the market react to Immutep Limited - ADR's Q2 2026 earnings?
The stock price moved down -2.94%, changed from $3.06 before the earnings release to $2.97 the day after.
When is Immutep Limited - ADR expected to report next?
The next earning report is scheduled for Jul 29, 2026.
What are the forecasts for Immutep Limited - ADR's next earnings report?
Based on 2
analysts, Immutep Limited - ADR is expected to report EPS of -- and revenue of $12.06M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement